Status:
COMPLETED
Detection of Schistosomiasis CAA in Travellers After High-risk Water Contact
Lead Sponsor:
Meta Roestenberg
Conditions:
Schistosomiasis
Eligibility:
All Genders
18-99 years
Brief Summary
Schistosomiasis is increasingly encountered among travellers returning from the tropics and is known for its focal endemicity, associated with the presence of the snail intermediate host in fresh wate...
Eligibility Criteria
Inclusion
- Any self-reported high risk water contact, including wading, showering, surfing, walking along wet shore bare-footed or washing with water from a high-risk source, within 12 weeks prior to reporting to the outpatient department
- Agreement to perform routine diagnostic procedures to diagnose schistosomiasis infection
- Willing to provide a maximum of three additional blood samples in addition to routine diagnostic procedures
- Able to provide informed consent
Exclusion
- Previous treatment for schistosomiasis
- Known positive schistosomiasis serology
- The use of immunosuppressive or immunomodulatory drugs at presentation that compromise the interpretation of schistosomiasis serology
Key Trial Info
Start Date :
January 1 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2019
Estimated Enrollment :
106 Patients enrolled
Trial Details
Trial ID
NCT02194712
Start Date
January 1 2015
End Date
September 1 2019
Last Update
November 18 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Academic Medical Center
Amsterdam, Netherlands, 1100 DD
2
Leiden University Medical Center
Leiden, Netherlands, 2333 ZA
3
Harbour Hospital
Rotterdam, Netherlands, 3011 TG